Challenges and potential for ovarian preservation with SERMs

Alison Ting, Brian K. Petroff

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tamoxifen (TAM) is a selective estrogen receptor modulator with tissue-specific effects on estrogen signaling used predominantly for treatment and chemoprevention of breast cancers. Recent studies have shown that TAM prevents infertility and decreases follicular loss from common cancer chemotherapy and radiation therapy in preclinical models. Here we review current and novel uses of selective estrogen receptor modulator s and advantages and challenges for translation of TAM for human fertility preservation.

Original languageEnglish (US)
Article number133
JournalBiology of Reproduction
Volume92
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Selective Estrogen Receptor Modulators
Tamoxifen
Fertility Preservation
Chemoprevention
Infertility
Estrogens
Radiotherapy
Breast Neoplasms
Drug Therapy
Neoplasms
Therapeutics

Keywords

  • Cancer
  • Fertility
  • Ovary
  • SERM
  • Tamoxifen

ASJC Scopus subject areas

  • Cell Biology

Cite this

Challenges and potential for ovarian preservation with SERMs. / Ting, Alison; Petroff, Brian K.

In: Biology of Reproduction, Vol. 92, No. 5, 133, 01.05.2015.

Research output: Contribution to journalArticle

@article{f5bc41c75fe04ff3afde4db6ed1149b0,
title = "Challenges and potential for ovarian preservation with SERMs",
abstract = "Tamoxifen (TAM) is a selective estrogen receptor modulator with tissue-specific effects on estrogen signaling used predominantly for treatment and chemoprevention of breast cancers. Recent studies have shown that TAM prevents infertility and decreases follicular loss from common cancer chemotherapy and radiation therapy in preclinical models. Here we review current and novel uses of selective estrogen receptor modulator s and advantages and challenges for translation of TAM for human fertility preservation.",
keywords = "Cancer, Fertility, Ovary, SERM, Tamoxifen",
author = "Alison Ting and Petroff, {Brian K.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1095/biolreprod.115.128207",
language = "English (US)",
volume = "92",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "5",

}

TY - JOUR

T1 - Challenges and potential for ovarian preservation with SERMs

AU - Ting, Alison

AU - Petroff, Brian K.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Tamoxifen (TAM) is a selective estrogen receptor modulator with tissue-specific effects on estrogen signaling used predominantly for treatment and chemoprevention of breast cancers. Recent studies have shown that TAM prevents infertility and decreases follicular loss from common cancer chemotherapy and radiation therapy in preclinical models. Here we review current and novel uses of selective estrogen receptor modulator s and advantages and challenges for translation of TAM for human fertility preservation.

AB - Tamoxifen (TAM) is a selective estrogen receptor modulator with tissue-specific effects on estrogen signaling used predominantly for treatment and chemoprevention of breast cancers. Recent studies have shown that TAM prevents infertility and decreases follicular loss from common cancer chemotherapy and radiation therapy in preclinical models. Here we review current and novel uses of selective estrogen receptor modulator s and advantages and challenges for translation of TAM for human fertility preservation.

KW - Cancer

KW - Fertility

KW - Ovary

KW - SERM

KW - Tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=84937041300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937041300&partnerID=8YFLogxK

U2 - 10.1095/biolreprod.115.128207

DO - 10.1095/biolreprod.115.128207

M3 - Article

C2 - 25810474

AN - SCOPUS:84937041300

VL - 92

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 5

M1 - 133

ER -